Acute aortic dissection in a patient with metastatic renal cell carcinoma treated with axitinib

被引：16
|
作者：
Niwa, Naoya [1 ]
Nishiyama, Toru [1 ]
Ozu, Choichiro [1 ]
Yagi, Yasuto [1 ]
Saito, Shiro [1 ]
机构：
[1] Natl Hosp Org Tokyo Med Ctr, Dept Urol, Tokyo 1528902, Japan
来源：
ACTA ONCOLOGICA | 2015年 / 54卷 / 04期
关键词：
D O I：
10.3109/0284186X.2014.963887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：561 / U165
页数：2
相关论文
共 50 条
  • [21] Axitinib Controlled Metastatic Renal Cell Carcinoma for 5 Years
    Takayama, Tatsuya
    Nagata, Masao
    Kai, Fumitake
    Sugiyama, Takayuki
    Ozono, Seiichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (07) : 747 - 751
  • [22] An alternative titration schedule of axitinib in metastatic renal cell carcinoma
    Alva, Vyshak
    Wood, Laura S.
    Elson, Paul
    Martin, Allison
    Beach, Jennifer
    Garcia, Jorge A.
    Rini, Brian I.
    BJU INTERNATIONAL, 2014, 114 : 1 - 2
  • [23] Axitinib-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic renal cell carcinoma
    Kogenta Nakamura
    Hiroshi Saiki
    Hiroyuki Muramatsu
    Shingo Morinaga
    Ikuo Kobayashi
    Keishi Kajikawa
    Genya Nishikawa
    Yoshiharu Kato
    Masahito Watanabe
    Kent Kanao
    Makoto Sumitomo
    International Cancer Conference Journal, 2017, 6 (4) : 197 - 199
  • [24] An alternative titration schedule of axitinib in metastatic renal cell carcinoma
    Venur, Vyshak Alva
    Wood, Laura S.
    Elson, Paul
    Martin, Allison
    Beach, Jennifer
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [25] Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
    Antoine Thiery-Vuillemin
    Emeline Orillard
    Guillaume Mouillet
    Fabien Calcagno
    Nadège Devillard
    Stéphane Bouchet
    Bernard Royer
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1273 - 1276
  • [26] Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
    Thiery-Vuillemin, Antoine
    Orillard, Emeline
    Mouillet, Guillaume
    Calcagno, Fabien
    Devillard, Nadege
    Bouchet, Stephane
    Royer, Bernard
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1273 - 1276
  • [27] LONG PROGRESSION FREE SURVIVAL WITH AXITINIB IN HEAVILY TREATED PATIENT WITH CHROMOPHOBE RENAL CELL CARCINOMA
    Doni, Laura
    Cerullo, Carmine
    Di Costanzo, Francesco
    ANTICANCER RESEARCH, 2014, 34 (05) : 2634 - 2635
  • [28] Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib
    Hideaki Miyake
    Ken-ichi Harada
    Satoshi Imai
    Akira Miyazaki
    Masato Fujisawa
    International Journal of Clinical Oncology, 2015, 20 : 796 - 801
  • [29] Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib
    Miyake, Hideaki
    Harada, Ken-ichi
    Imai, Satoshi
    Miyazaki, Akira
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 796 - 801
  • [30] Case report of a patient being treated for metastatic renal cell carcinoma
    Langiewicz, Przemyslaw
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A25 - A26
12345